Telemedicine System and Intelligent Monitoring System Construction of Pediatric Asthma Based on the Electronic Stethoscope
Asthma
About this trial
This is an interventional health services research trial for Asthma focused on measuring Pediatric, Asthma Control, Electronic Stethoscope
Eligibility Criteria
Inclusion Criteria: Diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" in the respiratory clinic of Shanghai Children's Medical Center from January 2023 to January 2025 Out-patient, female or male, 3 years old≤ age < 6 years old long-term maintenance therapy with inhaled glucocorticoids or concomitant leukotriene receptor antagonists Equipped with a household atomizer or spacer, it can afford the inhalation therapy of short-acting β2 receptor agonists (SABA) at home The subjects or subjects' caregiver must have a smart phone with Android or Harmony system at their disposal The guardian agrees to participate in the study and signs the informed consent form Exclusion Criteria: Acute exacerbation of asthma 30 days before enrollment (receive short-term prednisone treatment, emergency department visit or hospitalization due to acute asthma attacks) Other chronic lung diseases, cardiovascular diseases, blood system diseases, immunodeficiency diseases, neurological diseases, genetic or chromosomal abnormalities and other underlying diseases Patients or their caregivers can't complete the collection of breath sound
Sites / Locations
- Shanghai Children's Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
electronic stethoscope group
control group
During the study, subjects who diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" will be assigned to the control group and the electronic stethoscope group, and receive 12 months standard treatment, prescribed by the investigators according to "Guideline for the diagnosis and optimal management of asthma in children". The patient's caregiver will be instructed to use an electronic stethoscope to coordinate treatment and complete follow-up.
During the study, subjects who diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" will be assigned to the control group and the electronic stethoscope group, and receive 12 months standard treatment, prescribed by the investigators according to "Guideline for the diagnosis and optimal management of asthma in children".